ArticleHuman pathology2016

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn's colitis.

Natalia Edison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.